Agency Aligns Purpose, Profit and Performance, Driving Higher Standards for Media Agencies LONDON, Feb. 4, 2025 /PRNewswire/ -- Assembly, a global media ...

Kodiak Sciences Inc. , a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases, announced today ...

Financial GeoVax Anticipates Significant 2025 Progress With Catalyst-Rich Milestones Across Key Programs 05.02.2025 / 15:06 CET/CEST The issuer is solely responsible for the content of this ...

This news release constitutes a 'designated news release' for the purposes of the Company's prospectus supplement dated October 3, 2024 to its ...

Milestone Pharmaceuticals Inc. (NASDAQ:MIST) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Milestone Pharmaceuticals Inc., a ...

ACLF clinical trials expected to initiate in 1Q253 clinical data readouts expected by year-end 2025 across the ACLF pipeline, including ...

Jason Barnard, President and CEO of Foremost Clean Energy, comments: “Today marks an exciting new chapter for our valued ...

“Break these into smaller, manageable tasks like establishing an emergency fund or investing in a diverse portfolio, and make sure to celebrate each milestone you reach. This not only keeps you ...

This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated October 3, 2024 to its short form base shelf prospectus dated September 11 ...

The FDA’s approval for expanded use reinforces LP-310’s potential as a new therapeutic option for OLP and supports ongoing clinical development efforts.

On January 29, Nasdaq reported its fourth quarter and full year 2024 earnings. Nasdaq’s results reflected a year of strong financial and operational performance as well as strategic execution across ...